Valeant Pharmaceuticals Intl Inc  

(Public, TSE:VRX)   Watch this stock  
Find more results for VRX
165.46
-0.32 (-0.19%)
Dec 19 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 165.41 - 170.06
52 week 116.01 - 170.45
Open 166.93
Vol / Avg. 2.36M/478,928.00
Mkt cap 55.08B
P/E 96.72
Div/yield     -
EPS 1.71
Shares 335.67M
Beta 0.32
Inst. own 84%
Feb 25, 2015
Q4 2014 Valeant Pharmaceuticals International Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jan 8, 2015
Valeant Pharmaceuticals International Inc 2015 Financial Guidance Call - 8:00AM EST - Add to calendar
Oct 20, 2014
Q3 2014 Valeant Pharmaceuticals International Inc Earnings Release
Oct 20, 2014
Q3 2014 Valeant Pharmaceuticals International Inc Earnings Call
  

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 13.44% -14.97%
Operating margin 33.26% -8.22%
EBITD margin - 51.28%
Return on average assets 4.03% -3.76%
Return on average equity 21.28% -19.60%
Employees 17,200 -
CDP Score - -

Address

2150 Saint-Elzear Blvd W
LAVAL, QC H7L 4A8
Canada
+1-514-7446792 (Phone)
+1-514-7446272 (Fax)

Website links

Description

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. The Company operates in five business segments: U.S. Neurology and Other, U.S. Dermatology, Canada and Australia, Branded Generics - Europe and Branded Generics -Latin America. Within its U.S. Dermatology segment and Branded Generic - Europe segment the Company generates service revenue from contract services in the areas of dermatology and topical medication. In June 2014, Akorn Inc sold its subsidiary, ECR Pharmaceuticals (ECR) to Valeant Pharmaceuticals International, Inc. In July 2014, the Company acquired PreCision Dermatology, Inc.

Officers and directors

J. Michael Michael Pearson Chairman of the Board, Chief Executive Officer
Age: 53
Bhaskar Chaudhuri Ph.D. President
Age: 59
Howard Bradley Schiller Chief Financial Officer, Executive Vice President, Director
Peter J. Blott Chief Financial Officer, Executive Vice President
Age: 50
Elisa A. Karlson Executive Vice President, Chief Administrative Officer
Age: 53
Robert Roswell Chai-Onn Executive Vice President, General Counsel, Corporate Secretary and Corporate Business Development
Age: 42
Steve T. Min Executive Vice President, General Counsel, Corporate Secretary
Age: 50
Ari Kellen Executive Vice President, Company Group Chairman
Laizer D. Kornwasser Executive Vice President, Company Group Chairman
Martin N Mercer Executive VP, International